ONCOSEC MEDICAL INCORPORATED Increase Decrease In Operating Lease Liability
ONCOSEC MEDICAL INCORPORATED reported Increase Decrease In Operating Lease Liability of -$222.10 thousand for the 6-month period ending 2023-01-31, per its 10-Q filed 2023-03-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingLeaseLiability · last filed 2023-03-14
- ONCOSEC MEDICAL INCORPORATED increase decrease in operating lease liability for the quarter ending 2023-01-31 was $40.69K.
- ONCOSEC MEDICAL INCORPORATED increase decrease in operating lease liability for the quarter ending 2022-10-31 was -$262.79K.
- ONCOSEC MEDICAL INCORPORATED increase decrease in operating lease liability for the quarter ending 2022-07-31 was -$253.90K.
- ONCOSEC MEDICAL INCORPORATED increase decrease in operating lease liability for the quarter ending 2022-04-30 was -$247.76K.
- ONCOSEC MEDICAL INCORPORATED increase decrease in operating lease liability for fiscal 2022 was -$845.48K.
- ONCOSEC MEDICAL INCORPORATED increase decrease in operating lease liability for fiscal 2021 was -$629.93K.
- ONCOSEC MEDICAL INCORPORATED increase decrease in operating lease liability for fiscal 2020 was -$967.81K.
| Period end | Increase Decrease In Operating Lease Liability 3 month | Increase Decrease In Operating Lease Liability 6 month | Increase Decrease In Operating Lease Liability 9 month | Increase Decrease In Operating Lease Liability 12 month |
|---|---|---|---|---|
| 2023-01-31 | $40.69K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-03-14 | -$222.10K 10-Q · filed 2023-03-14 | -$476.00K derived: sum of 3 quarters · filed 2023-03-14 | -$723.77K derived: sum of 4 quarters · filed 2023-03-14 |
| 2022-10-31 | -$262.79K 10-Q · filed 2022-12-15 | -$516.70K derived: sum of 2 quarters · filed 2022-12-15 | -$764.46K derived: sum of 3 quarters · filed 2022-12-15 | -$1.00M derived: sum of 4 quarters · filed 2023-03-14 |
| 2022-07-31 | -$253.90K derived: 10-K 12 month − 10-Q 9 month · filed 2022-10-31 | -$501.67K derived: sum of 2 quarters · filed 2022-10-31 | -$740.11K derived: sum of 3 quarters · filed 2023-03-14 | -$845.48K 10-K · filed 2022-10-31 |
| 2022-04-30 | -$247.76K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-06-14 | -$486.21K derived: sum of 2 quarters · filed 2023-03-14 | -$591.58K 10-Q · filed 2022-06-14 | -$815.04K derived: sum of 4 quarters · filed 2023-03-14 |
| 2022-01-31 | -$238.44K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-03-14 | -$343.82K 10-Q · filed 2023-03-14 | -$567.28K derived: sum of 3 quarters · filed 2023-03-14 | -$784.37K derived: sum of 4 quarters · filed 2023-03-14 |
| 2021-10-31 | -$105.37K 10-Q · filed 2022-12-15 | -$328.84K derived: sum of 2 quarters · filed 2022-12-15 | -$545.93K derived: sum of 3 quarters · filed 2022-12-15 | -$588.54K derived: sum of 4 quarters · filed 2022-12-15 |
| 2021-07-31 | -$223.47K derived: 10-K 12 month − 10-Q 9 month · filed 2022-10-31 | -$440.56K derived: sum of 2 quarters · filed 2022-10-31 | -$483.17K derived: sum of 3 quarters · filed 2022-10-31 | -$629.93K 10-K · filed 2022-10-31 |
| 2021-04-30 | -$217.09K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-06-14 | -$259.70K derived: sum of 2 quarters · filed 2022-06-14 | -$406.46K 10-Q · filed 2022-06-14 | -$606.73K derived: sum of 4 quarters · filed 2022-06-14 |
| 2021-01-31 | -$42.61K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-03-15 | -$189.37K 10-Q · filed 2022-03-15 | -$389.64K derived: sum of 3 quarters · filed 2022-03-15 | |
| 2020-10-31 | -$146.76K 10-Q · filed 2021-12-15 | -$347.03K derived: sum of 2 quarters · filed 2021-12-15 | ||
| 2020-07-31 | -$200.27K derived: 10-K 12 month − 10-Q 9 month · filed 2021-10-29 | -$967.81K 10-K · filed 2021-10-29 | ||
| 2020-04-30 | -$767.54K 10-Q · filed 2021-06-11 |